2021
Association of Heart and Lung Radiation Dose With COVID-Related Mortality
Talcott W, Peters G, Yu J, Park H. Association of Heart and Lung Radiation Dose With COVID-Related Mortality. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e424-e425. PMCID: PMC8536215, DOI: 10.1016/j.ijrobp.2021.07.1212.Peer-Reviewed Original ResearchLung radiation doseCOVID-19 infectionCOVID-related mortalityStudy cohortRadiation therapyOdds ratioRadiation dosePoor COVID-19 outcomesCOVID-19 positive patientsDosimetric parametersNon-metastatic patientsMultivariable logistic regressionConfidence intervalsNormal lung tissuesCOVID-19 outcomesLung radiation therapyCOVID-19MATERIAL/METHODSPrior radiation doseCardiovascular sequelaeEvaluable patientsHeart dosesHeart V5Lung V5Association of heart
2019
Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database
Chowdhary M, Lee A, Gao S, Wang D, Barry PN, Diaz R, Bagadiya NR, Park HS, Yu JB, Wilson LD, Moran MS, Higgins SA, Knowlton CA, Patel KR. Is Proton Therapy a “Pro” for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database. Frontiers In Oncology 2019, 8: 678. PMID: 30693271, PMCID: PMC6339938, DOI: 10.3389/fonc.2018.00678.Peer-Reviewed Original ResearchLymph node irradiationNational Cancer DatabaseOverall survivalMultivariable analysisBreast cancerCancer DatabaseProton radiotherapyNon-metastatic breast cancerCox proportional hazards modelHigher heart dosesN2-N3 diseaseMultivariate logistic analysisProportional hazards modelAcademic facilitiesLogistic regression modelsHeart dosesAdjuvant radiotherapyNode irradiationHazard ratioNode positivityClinical benefitClinical trialsPRT patientsStage 0Hazards model